Moreover, lncRNA ACTA2-AS recruits EZH2 to the TSC2 gene promoter, suppressing TSC2 expression, inhibiting autophagy, promoting apoptosis in cisplatin-resistant NSCLC cells, and limiting tumor progression. The gene discussed is TSC2; the disease is non-small cell lung carcinoma.